JSPR
Jasper Therapeutics, Inc.Company with tickers: JSPR, JSPRW
CIK
1788028
CUSIP
471871202
Shares Outstanding
27,996,819
13F Activity (30d)
53 filings
51 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-09 | 2026-06-03 | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-21 | 2026-05-15 | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2026-01-07 | 2026-01-02 | |
| 8-K | 2025-12-02 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-09-19 | 2025-09-18 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-07-09 | 2025-07-08 | |
| 8-K | 2025-07-07 | — | |
| 8-K | 2025-07-03 | — | |
| 8-K | 2025-06-16 | 2025-06-14 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-03-19 | 2025-03-14 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-08 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-15 | 2024-10-14 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-20 | 2024-06-17 | |
| 8-K | 2024-06-12 | 2024-06-06 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 10-K | 2024-03-05 | 2023-12-31 | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-02-06 | — | |
| 8-K | 2024-01-04 | 2024-01-03 | |
| 8-K | 2024-01-02 | — | |
| 8-K | 2023-12-20 | 2023-12-15 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-11-01 | 2023-10-30 | |
| 8-K | 2023-10-20 | 2023-10-18 | |
| 8-K | 2023-10-10 | — | |
| 8-K | 2023-10-10 | 2023-10-09 | |
| 8-K | 2023-09-25 | 2023-09-21 | |
| 8-K | 2023-09-21 | — | |
| 10-Q | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-08-11 | — | |
| 8-K | 2023-06-20 | — |
Showing 1–50 of 107 filings